BFC Planning’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13.4K Buy
161
+47
+41% +$3.86K ﹤0.01% 2235
2026
Q2
$7.57K Sell
114
-25
-18% -$2.12K ﹤0.01% 2502
2026
Q1
$13.8K Buy
139
+43
+45% +$5.61K ﹤0.01% 1883
2025
Q4
$11.7K Buy
96
+3
+3% +$376 ﹤0.01% 2001
2025
Q3
$10.4K Buy
93
+3
+3% +$351 ﹤0.01% 1901
2025
Q2
$12.1K Sell
90
-32
-26% -$3.51K ﹤0.01% 1716
2025
Q1
$8.21K Buy
122
+21
+21% +$1.44K ﹤0.01% 1850
2024
Q4
$6.3K Buy
101
+74
+274% +$6.89K ﹤0.01% 1939
2024
Q3
$4.24K Buy
+27
New +$4.16K ﹤0.01% 2055

Other funds holding TMDX

BFC Planning's TMDX Position: Q3 2026 in Review

BFC Planning increased its Transmedics (TMDX) stake by 41% in Q3 2026, buying an estimated $3.86K and bringing the position to 161 shares worth $13.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2235.

BFC Planning first reported a position in TMDX in Q3 2024 and has held it in 9 quarters since. The position peaked at $13.8K in Q1 2026. 308 funds tracked by Wall St. Rank hold TMDX as of Q3 2026.

  • BFC Planning held 161 shares of Transmedics worth $13.4K as of Q3 2026.
  • BFC Planning bought 47 Transmedics shares in Q3 2026, an estimated $3.86K.
  • Transmedics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2235 holding.
  • BFC Planning first reported a position in Transmedics in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's Transmedics position peaked at $13.8K in Q1 2026.
  • 308 funds tracked by Wall St. Rank held Transmedics as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.